You are subscribed to the Optometry Times Issue Alert.

Optometry Times Issue Alert

eNewsletter Subscribe

Print Subscribe

Digital Edition Subscribe

January 24, 2014

Web Version  |  Share with a colleague  |  View Digital Edition

Facebook Like   Twitter Tweet

CHECK OUT OUR JANUARY ISSUE

Study: long-term use of oral contraceptives may lead to glaucoma

According to a recent study, women who have taken oral contraceptives for 3 or more years are twice as likely to suffer from glaucoma. What do your patients need to know?
» Full article

Exclusive: NBEO unveils board certification process

Recently, the National Board of Examiners in Optometry (NBEO) launched a program to offer board certification to optometrists, with the first test taking place in March 2014. » Full article

OD Q&A: Brien Holden

Check out our extended interview with Dr. Brien Holden. » Full article

A different approach to treating demodex blepharitis

While new treatments under consideration include topical or oral ivermectin and Greenbug for People cedar oil, a new treatment paradigm is taking shape, and tea tree oil is at the heart of it. » Full article

Preoperative considerations in patients with cataracts and pseudoexfoliation syndrome

Preoperative evaluation of patients with pseudoexfoliation (PXF) syndrome is essential in preparing for and potentially preventing complications during phacoemulsification. Patients with PXF have been documented to have an accelerated rate of cataracts, both nuclear and subcapsular. » Full article

Amniotic membrane in ocular surface disease

The innate properties of amniotic membrane make it ideal for wound healing/tissue regeneration and in eye care, the management of corneal and conjunctiva disease/reconstruction. » Full article

 

Downloads

Optometry Times App - Download Optometry Times Digital Edition - Download

You are subscribed to the Optometry Times Issue Alert.

Related Articles

Diagnosing Demodex

Opinion: The unintended consequences of optometric board certification

New technologies to improve global eye health

It's all about the ocular surface!

 
Powered by Modern Medicine Advanstar Medical Communications Group